DNMT3A, IDH1, IDH2 and RUNX1 mutations were frequent in MDS, MDS/MPN and AML NOS, AML with MDS related changes and AML secondary to MPN. This evidence concerns the gene IDH1 and myeloproliferative neoplasm.